Literature DB >> 9466170

Comorbidities in social phobia.

Y Lecrubier1, E Weiller.   

Abstract

In a sample of 2096 consecutive primary care patients recruited in the Paris region, social phobia was a highly prevalent disorder (5.1%). The most frequent comorbid condition was depressive episode, which affected 70% of patients with social phobia of early onset (at less than 15 years of age), while the highest association was with agoraphobia (odds ratio 10.4). No association was observed with generalized anxiety disorder. Alcohol abuse and suicidal ideation and attempts are also commonly associated with social phobia. However, when patients presented to a general practitioner with comorbid depression present, 76% were recognized as cases (though only 11% were identified as having an anxiety disorder), but in the absence of depression, only 46% were identified as cases. Given the degree of disability caused by social phobia, there is an obvious need for improved education of both doctors and patients regarding its status as a disorder, and its treatability.

Entities:  

Mesh:

Year:  1997        PMID: 9466170     DOI: 10.1097/00004850-199710006-00004

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  3 in total

1.  Social anxiety disorder and alcohol use disorder co-morbidity in the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  F R Schneier; T E Foose; D S Hasin; R G Heimberg; S-M Liu; B F Grant; C Blanco
Journal:  Psychol Med       Date:  2010-06       Impact factor: 7.723

2.  Social anxiety and its effect on self-efficacy among family medicine residents in Riyadh.

Authors:  Mohammed Abdullah Al-Ruwaili; Yousef Abdullah Al-Turki; Abdulrahman Alardan
Journal:  J Family Med Prim Care       Date:  2018 Mar-Apr

3.  Short-term Dynamic Psychotherapy versus Sertraline in Treatment of Social Phobia.

Authors:  Mehryar Nader-Mohammadi Moghadam; Mohammad-Kazem Atef-Vahid; Ali-Asghar Asgharnejad-Farid; Amir Shabani; Fahimeh Lavasni
Journal:  Iran J Psychiatry Behav Sci       Date:  2015-06-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.